Citations

Clear

45 citation(s) found for "Shapiro, Brian".

Signs of Increased Intrapericardial Pressure on Chest Computed Tomography
Rojas, Carlos, Padilla, Gary, Feldhaus, Jacob M., Rajan, Celin, Shapiro, Brian P. , Mergo, Patricia J. , Livingston, David H. , Bowman, Andrew W.

Mayo Clinic

Journal of Thoracic Imaging | February 7, 2020 | Volume: 35 | Issue: 3 | Pages: 143-152

10.1097/rti.0000000000000475 | PMID 32073542 Get It

We sought to describe incidental imaging features of increased intrapericardial pressure due to pericardial effusion on chest computed tomography (CT) and correlate them with cardiac CT, cardiac magnetic resonance imaging, and echocardiography. It is important for the radiologist to become familiar with imaging findings of increased intrapericardial pressure in the setting of pericardial effusion when identified on chest CT. Recognizing the imaging findings of increased intrapericardial pressure can better guide the care of these patients.
Eosinophillic Myocarditis Secondary to Metastatic Melanoma
Bryde, Robyn , Ray, Jordan , Shapiro, Brian P. , Bryde, Robyn E , Ray, Jordan C , Sacco, Keith A , Sacco, Keith , Cooper, Leslie T.

Mayo Clinic

Radiology: Cardiothoracic Imaging | November 12, 2019 | Volume: 1 | Issue: 4 | Pages: e190076

10.1148/ryct.2019190076 | PMID 32076668 Get It

Abstract P143: Multifaceted Roles of Gut Microbiome and Bacterial Metabolites in Pulmonary Arterial Hypertension
Kim, Seungbum S, Walejko, Jacquelyn M., Ray, Jordan , Richards, Elaine M. , Shapiro, Brian P. , Raizada, Mohan K. , Rigatto, Katya , Gazzana, Marcelo Basso , Knorst, Marli Maria , Pepine, Carl J.

Mayo Clinic

Hypertension | September 4, 2019 | Volume: 74 | Issue: Suppl_1 | Pages: No page available

10.1161/hyp.74.suppl_1.p143 Get It

Objectives: Pulmonary arterial hypertension (PAH) is a deadly disease without any effective cure. Identification of the PAH-associated gut microbiome may shift conceptual paradigms of the disease that could lead to new therapeutic advancement. We tested the hypothesis that PAH patients have distinct gut microbiome composition contributing to PAH that predicts the disease. Methods: A total of 71 participants were recruited. Fecal microbiomes of 18 type 1 PAH patients (mean pulmonary arterial pressure [mPAP] 57.4±16.7 mmHg) and 13 reference subjects were compared by shotgun metagenomics methods. Plasma from 22 PAH patients (mPAP 48.3± 18.4 mmHg) and 18 reference subjects was used in untargeted metabolomic analysis. Results: Significant taxonomic and functional changes in the microbiome of the PAH cohort were observed. PAH patients had increased gut barrier dysfunction and inflammation as evidenced by plasma markers and metagenomics. A random forest model predicted PAH from gut microbiome composition with 82.6% accuracy. Changes in the gut microbiome were associated with purine metabolism, arginine biosynthesis, trimethylamine production and tryptophan biosynthesis, all previously associated with PAH. Area under the curve of the multi-variate receiver operating characteristics (ROC) plot for metabolites of these pathways had a predictive accuracy of 0.965. Conclusions: The gut microbiome/metabolites of PAH patients predict disease in random forest models and ROC analyses. The unique PAH gut microbiome influences carnitine, arginine and purine metabolisms contributing to pathophysiology. These highlight previously unknown roles of gut bacteria and their metabolites in PAH that could lead to new therapeutic or management paradigms.
Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction
Shapiro, Brian P. , McGoon, Michael D., Redfield, Margaret M. , Nishimura, Rick A.

Mayo Clinic

Advances in Pulmonary Hypertension | May 7, 2019 | Volume: 5 | Issue: 1 | Pages: 13-20

10.21693/1933-088x-5.1.13 Get It

Ask the Expert: Is Cardiac Magnetic Resonance Imaging Underutilized in the Diagnosis of Pulmonary Hypertension?
Studer, Sean , Ray, Jordan , Blackshear, Joseph L., Safford, Robert E. , Mergo, Patricia J. , Shapiro, Brian P. , Burger, Charles D.

Mayo Clinic

Advances in Pulmonary Hypertension | February 26, 2019 | Volume: 14 | Issue: 2 | Pages: 102-104

10.21693/1933-088x-14.2.102 Get It

Abstract P167: Altered Gut Microbiome Contributes to Metabolite Biomarkers in Patients With Pulmonary Hypertension
Kim, Seungbum , Walejko, Jacquelyn M., Jordan, Ray, Shapiro, Brian P. , Richards, Elaine M. , Raizada, Mohan K. , Rigatto, Katya , Pepine, Carl J.

Mayo Clinic

Hypertension | December 6, 2018 | Volume: 72 | Issue: Suppl_1 | Pages: No page available

10.1161/hyp.72.suppl_1.p167 Get It

Objectives: Pulmonary arterial hypertension (PAH) is a cardiopulmonary disease without effective cure. The objective of this study is to test the hypothesis that PAH patients have a distinct gut microbiome composition acting as a driving force for the increased PAH metabolic biomarkers, acyl carnitines and urate. Methods: Fecal samples from 18 type 1 PAH patients (mean pulmonary arterial pressure [mPAP] 57.4±16.7 mmHg) and 13 reference subjects in Brazil were collected for comparison of microbiome using shotgun metagenomics. Plasma samples from 33 type I PAH patients (mPAP 51.7± 13.5 mmHg) and 19 reference subjects in the USA were used for untargeted metabolomic analysis. Results: More than 80 bacterial taxa were differentially enriched in the microbiomes of the PAH cohort. Random forest machine-learning algorithm predicted PAH patients with 82.4% accuracy from their gut microbiome composition. The most increased taxa in the PAH microbiome were trimethylamine (TMA) producing bacteria like Collinsella (P=0.0037). The PAH metabolome also showed increases of gut microbiome-derived short chain acyl carnitines like isubutyrylcarnitine (P=0.010) and valerylcarnitine (P=0.030), which are the precursors of TMA. In addition, increased urate (P=0.0004) and allantoin (P=0.027) in PAH plasma correlated with significantly increased enzymes producing urate in the PAH microbiome (purine metabolism (P=0.017) and xanthine oxidase (P<0.05)). Conclusion: These findings suggest that the random forest modeling of the gut microbiome composition can be used for prediction of PAH and that the unique gut microbiome of PAH influences acyl carnitines and urate metabolism to contribute to pathophysiology.
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)
Shapiro, Brian P. , Ambrosius, Walter T. , Blackshear, Joseph L., Whelton, Paul K. , Oparil, Suzanne , Dwyer, Jamie P. , Kostis, William J. , Lioudis, Michael , Pisoni, Roberto, Rosendorff, Clive , Haley, William E. , Dwyer, Jamie P , Cushman, William C. , Beddhu, Srinivasan , Gren, Lisa H.

Mayo Clinic

Hypertension | April 30, 2018 | Volume: 71 | Issue: 6 | Pages: 1064-1074

10.1161/hypertensionaha.117.10646 | PMID 29712745 Get It

Intensive systolic blood pressure (SBP) control improved outcomes in SPRINT (Systolic Blood Pressure Intervention Trial). Our objective was to expand on reported findings by analysis of baseline characteristics, primary outcomes, adverse events, follow-up blood pressure, and medication use differences by baseline SBP (tertile 1 [T1], <132; tertile 2 [T2], 132–145; and tertile 3 [T3], >145 mm Hg). Participants with higher baseline SBP tertile were more often women and older, had higher cardiovascular risk, and lower utilization of antihypertensive medications, statins, and aspirin. Achieved SBP in both treatment arms was slightly higher in T2 and T3 compared with T1 and fewer in the T3 groups achieved SBP targets compared with T1 and T2 groups. The primary composite outcome with intensive versus standard SBP treatment was reduced by 30% in T1, 23% in T2, and 17% in T3 with no evidence of an interaction ( P =0.77). Event rates were lower in the intensive arm, and there was no evidence that this benefit differed by SBP tertile. There was no difference in the hazard for serious adverse events in any of the 3 tertiles. Medication utilization differed across the SBP tertiles at baseline with a lesser percentage of diuretics and angiotensin-converting enzyme inhibitors/angiotensin receptor blocker drugs in the higher tertiles—a finding that reversed during the trial. The beneficial effects of intensive SBP lowering were not modified by the level of baseline SBP. Within the parameters of this population, these findings add support for clinicians to treat blood pressure to goal irrespective of baseline SBP.
A novel semiquantitative assessment of right ventricular systolic function with a modified subcostal echocardiographic view
Alvarez, Andres Borja, Danaraj, Jonathan, Freeman, Michelle L., Lee, Augustine S. , Mookadam, Farouk , Shapiro, Brian P. , Díaz-Gómez, José L , Danaraj, Jonathan J, Ramakrishna, Harish , Díaz‐Gómez, José L. , Mookadam, Farouk

Mayo Clinic

Echocardiography | October 14, 2016 | Volume: 34 | Issue: 1 | Pages: 44-52

10.1111/echo.13400 | PMID 27739100 Get It

ObjectivesThe tricuspid annular plane systolic excursion (TAPSE) is a validated measure of right ventricular function; however, the apical echocardiographic window varies and has limitations in intensive care unit (ICU) patients receiving mechanical ventilation or those with underlying disease and air entrapment. We aimed to evaluate the subcostal echocardiographic assessment of tricuspid annular kick (SEATAK) as an alternative to TAPSE in critically ill patients.MethodsTo measure SEATAK, we obtained the subcostal inferior vena cava view and used M‐mode to measure excursion of the tricuspid annulus (kick). Analysis was performed with JMP for Bland‐Altman and Spearman correlations.ResultsWe evaluated 45 patients, 26 (57.8%) of whom were women, with a mean age of 60.8 years. We were not able to obtain the apical view to measure TAPSE in 8.9% of the patients. In contrast, SEATAK was measured in all patients. The mean SEATAK and TAPSE were 1.62 cm and 1.93 cm, respectively, with a mean pairwise difference of −0.26 cm (95% CI: −0.19 to −0.35), with the SEATAK value being lower than TAPSE. The overall correlation was strong and significant (ρ = .86, P=.03). The graphical correlation was maintained between TAPSE and SEATAK and the degree of RVF.ConclusionIn patients presenting with RVF in the ICU (or in situations where the apical echocardiographic view is suboptimal for tricuspid annular assessment), SEATAK can be an alternative to TAPSE. Further research is needed to validate and determine the sensitivity and specificity of SEATAK for RVF prognostication.
Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy
Kim, Eun Kyoung , Chang, Sung‐A , Choi, Jin‐Oh , Glockner, James F., Shapiro, Brian P. , Jang, Shin Yi , Kim, Sung Mok , Oh, Jae K. , Glockner, James, Fine, Nowell, Miller, Wayne, Choe, Yeon Hyeon , Fine, Nowell Mark , Miller, Wayne L. , Lee, Sang‐Chol

Mayo Clinic

Korean Circulation Journal | January 15, 2016 | Volume: 46 | Issue: 1 | Pages: 41

10.4070/kcj.2016.46.1.41 | PMID 26798384 Get It

Emerging Role of Cardiovascular CT and MRI in the Evaluation of Stroke
Pagán, Ricardo J. , Parikh, Pragnesh , Mergo, Patricia J. , Gerber, Thomas C., Mankad, Rekha , Freeman, William D. , Shapiro, Brian P. , Freeman, William D , Mankad, Rekha

Mayo Clinic

American Journal of Roentgenology | January 23, 2015 | Volume: 204 | Issue: 2 | Pages: 269-280

10.2214/ajr.14.13051 | PMID 25615749 Get It